These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11192352)

  • 1. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?
    Hjalmarson A
    Basic Res Cardiol; 2000; 95 Suppl 1():I41-5. PubMed ID: 11192352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric therapy with beta-blockers.
    Hjalmarson A
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postinfarction use of beta-blockers in elderly patients.
    Aronow WS
    Drugs Aging; 1997 Dec; 11(6):424-32. PubMed ID: 9413700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers use from the general to the hemodialysis population.
    Aoun M; Tabbah R
    Nephrol Ther; 2019 Apr; 15(2):71-76. PubMed ID: 30718084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased survival with beta-blockers: importance of ancillary properties.
    Soriano JB; Hoes AW; Meems L; Grobbee DE
    Prog Cardiovasc Dis; 1997; 39(5):445-56. PubMed ID: 9122425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers and sudden cardiac death.
    Kendall MJ; Lynch KP; Hjalmarson A; Kjekshus J
    Ann Intern Med; 1995 Sep; 123(5):358-67. PubMed ID: 7625625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial data on the cardioprotective effects of beta-blockade.
    Kendall MJ
    Basic Res Cardiol; 2000; 95 Suppl 1():I25-30. PubMed ID: 11192348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockade in heart failure: selective versus nonselective agents.
    Metra M; Nodari S; Dei Cas L
    Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.